GSC
BIS icon

Ground Swell Capital’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Ground Swell Capital’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$29K Buy
+61
New +$32.5K 0.05% 375

Other funds holding BIS

HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Ground Swell Capital's BIS Position: Q3 2014 in Review

Ground Swell Capital opened a new position in ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2014: 61 shares worth $29K. The stake represents 0.05% of the portfolio and ranks #375 among its holdings.

16 funds tracked by Wall St. Rank hold BIS as of Q3 2014.

  • Ground Swell Capital held 61 shares of ProShares UltraShort NASDAQ Biotechnology worth $29K as of Q3 2014.
  • ProShares UltraShort NASDAQ Biotechnology was a new Ground Swell Capital position in Q3 2014.
  • ProShares UltraShort NASDAQ Biotechnology made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #375 holding.
  • 16 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.